Belimumab
- 29 April 2011
- journal article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 10 (5) , 335-336
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Biological therapy for lupus nephritis—tribulations and trialsNature Reviews Rheumatology, 2010
- B cells as therapeutic targets in SLENature Reviews Rheumatology, 2010
- A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosusArthritis Care & Research, 2009
- Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic EffectsToxicological Sciences, 2006
- Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulatorArthritis & Rheumatism, 2003
- Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus ErythematosusThe Journal of Immunology, 2001
- BLyS: Member of the Tumor Necrosis Factor Family and B Lymphocyte StimulatorScience, 1999